| VRX Silica Limited (VRX) ORDINARY FULLY PAID |
Materials |
$38 |
Renounceable Rights Issue to Raise up to $6.2 million
|
27 May 2026 8:47AM |
$0.049 |
$0.039 |
fallen by
20.41%
|
|
VRX - Price-sensitive ASX Announcement
Full Release
Key Points
- 1 for 5 renounceable rights issue at 4 cents per share
- Discount of 18.4% to last closing price
- 27.3% discount to 90-day VWAP
- 1 free attaching option per 2 new shares
- Option exercise price of 10 cents, expiring 30 June 2028
- Partially underwritten up to $2 million by Mahe Capital
- Funds for Arrowsmith North, Arramall purchase, Muchea project
- Rights trading begins 1 June 2026
- Offer closes 19 June 2026
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MinRex Resources Limited (MRR) ORDINARY FULLY PAID |
Materials |
$33 |
2026 Growth and Execution Plan
|
27 May 2026 8:47AM |
$0.017 |
$0.016 |
fallen by
8.82%
|
|
MRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Maximizing Tlamino Project value by targeting JORC 2012 resources conversion.
- Advancing statutory permitting pathway for the Tlamino Project.
- Economic revaluation of Tlamino amid increased gold and silver prices.
- Executing a dual-stream strategy for near-term and long-term value creation.
- Fully funded ~7,000m drilling program at Tlamino.
- Maintaining stakeholder engagement and community relationships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$220 |
Mayne Pharma to present at Jefferies Healthcare Conference
|
27 May 2026 8:44AM |
$2.340 |
$2.710 |
risen by
15.81%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$600 |
Update - Notification of buy-back - FPR
|
27 May 2026 8:44AM |
$2.800 |
$2.810 |
risen by
0.36%
|
|
| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$58 |
BMB18 clinical trial expands to dual site
|
27 May 2026 8:43AM |
$0.240 |
$0.255 |
risen by
6.25%
|
|
BIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Multi-centre BMB18 clinical trial across Australia and Greece.
- Inclusion of Harokopio University of Athens as a second site.
- Randomised, double-blind, placebo-controlled study with 240 participants.
- Assessment of two BMB18 dosages over six-week intervention.
- Aims to produce first human clinical evidence for Lactiplantibacillus plantarum strain.
- BMB18 is Biome's first wholly proprietary strain.
- Recruitment commencing within Q4 FY26 timeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$143 |
Aeromedical Study De-Risks Rural & Remote Stroke Use Cases
|
27 May 2026 8:40AM |
$1.710 |
$1.540 |
fallen by
9.94%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of aeromedical feasibility and usability study for First Responder Brain Scanner.
- Study conducted with Royal Flying Doctor Service, Australian Stroke Alliance, and South Australian Ambulance Service.
- First Responder Brain Scanner effectively deployed in real-world aeromedical environments.
- Positive feedback from operators, with scan data quality unaffected by flight conditions.
- Study de-risks device's rural and remote stroke care use cases.
- EMVision received a $400,000 milestone payment under the Australian Stroke Alliance Project Agreement.
- The device is being evaluated in pre-hospital use cases including Mobile Stroke Unit and road ambulance settings.
- Production equivalent units in development for data collection and regulatory clearance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$22 |
Scoping Study Confirms Development Opportunity for Hyperion
|
27 May 2026 8:39AM |
$0.081 |
$0.065 |
fallen by
19.75%
|
|
PRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Scoping Study confirms development opportunity for Hyperion Gold Deposit.
- Hyperion is located in the Tanami Region, Northern Territory, Australia.
- Study shows geologic and mining feasibility for advanced studies.
- Production target of 4.2 Mt at 1.9 g/t Au for 260Koz of gold.
- Mineral resources categorized as Indicated and Inferred.
- Significant exploration potential as mineralization remains open.
- Four-year contractor mining operation planned.
- Further work needed for prefeasibility level, including geotechnical and environmental studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,006 |
ASX Listing Rule 3.19 notification
|
27 May 2026 8:36AM |
$0.695 |
$0.875 |
risen by
25.90%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$173 |
Appointment of Chief Financial Officer
|
27 May 2026 8:35AM |
$0.165 |
$0.165 |
fallen by
0%
|
|
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$8,170 |
Update - Notification of buy-back - LNW
|
27 May 2026 8:35AM |
$112.100 |
$106.030 |
fallen by
5.41%
|
|
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$153 |
Update - Notification of buy-back - ATA
|
27 May 2026 8:32AM |
$0.470 |
$0.415 |
fallen by
11.70%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$14 |
Update - Notification of buy-back - 5GN
|
27 May 2026 8:32AM |
$0.080 |
$0.054 |
fallen by
32.50%
|
|
| Muzinich BDC Income Fund - Active ETF (BDCI) MUZINICH BDC INCOME FUND - ACTIVE ETF |
- |
$3 |
Distribution for month ending 31 May 2026
|
27 May 2026 8:31AM |
$19.150 |
$19.540 |
risen by
2.04%
|
|
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$55 |
Distribution for month ending 31 May 2026
|
27 May 2026 8:31AM |
$2.420 |
$2.390 |
fallen by
1.24%
|
|
| Yugo Metals Limited (YUG) ORDINARY FULLY PAID |
Materials |
$20 |
Gold discovery in first-ever drilling results from Erak
|
27 May 2026 8:31AM |
$0.090 |
$0.048 |
fallen by
46.67%
|
|
YUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Yugo Metals announces gold discovery from first-ever drilling at Erak Prospect.
- Five diamond drillholes completed, intersecting significant mineralised alteration zones.
- Prominent phyllic alteration associated with gold-bearing zones.
- Drillhole ERDD006 showed 34 meters of alteration in the eastern part of Erak.
- Polymetallic mineralisation includes gold, silver, copper, and antimony.
- Key intersection: 8m at 1.2 AuEq g/t, including 4m with specific mineral content.
- Ongoing drilling aims to explore mineralisation extensions.
- Future drilling to target high previous trenching results for gold.
- Results confirm potential for significant growth at the Erak gold system.
- Initial results are promising, with further assays pending.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| McPherson's Limited (MCP) ORDINARY FULLY PAID |
Consumer Staple |
$22 |
Update - Notification of buy-back - MCP
|
27 May 2026 8:29AM |
$0.130 |
$0.150 |
risen by
15.38%
|
|
| LGI Limited (LGI) ORDINARY FULLY PAID |
Utilities |
$243 |
Chair and Non-Executive Director Succession
|
27 May 2026 8:29AM |
$3.430 |
$2.350 |
fallen by
31.49%
|
|
| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$468 |
2026 AGM Addresses to Shareholders and Presentation
|
27 May 2026 8:29AM |
$1.500 |
$1.390 |
fallen by
7.33%
|
|
AGI - Price-sensitive ASX Announcement
Full Release
Key Points
- The annual general meeting took place on 27 May 2026.
- Ainsworth Game Technology Limited reported revenue of $290.8 million for the financial year ended 31 December 2025.
- The underlying EBITDA was $48.0 million, with a statutory loss due to various non-cash impairments and adjustments.
- The A-Star Raptor™ cabinet was launched, contributing significantly to revenue growth, especially in the Asia Pacific region.
- There was a noticeable increase in domestic and international revenues despite currency translation losses.
- Re-election and election of directors, including the re-election of Mr. Graeme John Campbell and Dr. Haig Edwin Asenbauer, and the election of Ms. Birgit Hermine Wimmer and Mr. Samuel Lawrence Levy.
- The focus remains on R&D with expenditures amounting to about 17% of group revenue.
- Dividends were suspended to maintain liquidity and focus on product development.
- The company remains committed to disciplined growth, operational accountability, and strategic initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum International Fund (Quoted Managed Hedge Fund) (PIXX) |
Financials |
$62 |
Quarterly Portfolio Disclosure - March 2026
|
27 May 2026 8:29AM |
$5.030 |
$4.710 |
fallen by
6.36%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$102 |
NZK Appoints Director
|
27 May 2026 8:28AM |
$0.200 |
$0.190 |
fallen by
5%
|
|
| VRX Silica Limited (VRX) ORDINARY FULLY PAID |
Materials |
$38 |
Arrowsmith North 2026 Updated BFS
|
27 May 2026 8:28AM |
$0.049 |
$0.039 |
fallen by
20.41%
|
|
VRX - Price-sensitive ASX Announcement
Full Release
Key Points
- VRX Silica Limited released the 2026 Updated BFS for the Arrowsmith North Silica Sand Project.
- The BFS confirms strong financial outcomes with an ungeared NPV8 of $179.2 million based on a 25-year mine life.
- Proved and Probable Ore Reserve of 221Mt at 99.5% SiO2 supports long-term production.
- The BFS includes revised capital and operating cost estimates.
- Product strategy targets international foundry and glass manufacturing markets with four distinct silica sand products.
- VRX Silica aims to finalize its Final Investment Decision soon.
- The project includes re-engineering for the processing plant relocation.
- Arrowsmith North is capable of producing high-quality sand for the foundry and glassmaking industries.
- Key regulatory approvals have been received from various Western Australian departments.
- The project supports a mining and rehabilitation methodology specific to the environment at Arrowsmith North.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum Asia Fund (Quoted Managed Hedge Fund) (PAXX) |
Financials |
$271 |
Quarterly Portfolio Disclosure - March 2026
|
27 May 2026 8:28AM |
$6.570 |
$5.730 |
fallen by
12.79%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$20 |
Ceasing to be a substantial holder
|
27 May 2026 8:27AM |
$0.033 |
$0.030 |
fallen by
9.09%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,983 |
AGM Material and Outlook
|
27 May 2026 8:27AM |
$22.350 |
$21.190 |
fallen by
5.19%
|
|
APE - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $13.0 billion for 2025, a 16.5% increase.
- Investment in CanadaOne Auto to expand into the Canadian market.
- Underlying EBITDAI rose to $620.9 million in 2025.
- Strategic partnership established with Mitsubishi Corporation.
- Continued focus on new energy vehicles and improved supply chain.
- Positive financial outlook for 2026 with expected record growth.
- Importance of disciplined capital allocation and strategic partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$20 |
Change in substantial holding
|
27 May 2026 8:27AM |
$0.033 |
$0.030 |
fallen by
9.09%
|
|
Call 1300 880 160
Start a chat
Schedule a call
